Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Autor:	Philip Jonsson, Yaelle Tuvy, Evi Vakiani, Laura H. Tang, David P. Kelsen, David B. Solit, D. Ilson, Margaret K. Callahan, Geoffrey Y. Ku, Jamie Riches, Nancy Bouvier, J.F. Hechtman, M.F. Berger, Nikolaus Schultz, Francisco Sanchez-Vega, Zsofia K. Stadler, Ritika Kundra, Yelena Y. Janjigian, Barry S. Taylor
Rok vydání:	2016
Předmět:	0301 basic medicine Genetics business.industry First line Hematology Computational biology DNA sequencing Blockade 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Medicine business
Zdroj:	Annals of Oncology. 27:vi208
ISSN:	0923-7534
DOI:	10.1093/annonc/mdw371.04
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8e326c1997b03382dd3e50f40b8c0970 https://doi.org/10.1093/annonc/mdw371.04 Zobrazit plný text záznamu